Highlights
1 patent
About
Proteomics Centered AI Powered Drug Discovery Platform
Protai has built an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered. The company is building machine learning models combining deep proteomics to identify up to 1 million proteoforms, including post-translational modifications, protein-protein interactions, quantifications, and different structural populations of proteins.
Identity
| Name | Protai |
|---|---|
| Slug | protai |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkNiWhu0JDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Tel Aviv-Yafo |
| HQ address | Tel Aviv, Israel |
Web & social
| Website | https://protai.bio |
|---|---|
| Careers page | https://www.protai.bio/careers |
| https://www.linkedin.com/company/74514047 | |
| Twitter / X | https://twitter.com/ProtaiBio |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial IntelligenceMachine LearningPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
data-analyticsbiotechnologydecision-supportdisease-managementproteinsdigital-healthcareartificial-intelligencedrug-discoverypersonalizationsoftware-platformpharma-companies
Funding
| Total raised | $20.0M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}